Earli, Inc.

Earli locates cancer early, when it is much more curable. Earli has an audacious mission: to make cancer a benign experience.

Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earli's technology *forces* cancer cells to make a precise synthetic, non-human biomarker to localize the cancer in a PET scanner. This is a completely new approach called Synthetic Biopsy. Earli’s $60M financing was led by Andreessen Horowitz, Khosla Ventures, Perceptive Advisors, Casdin Capital, Sands Capital,

One Glaring Problem in the U.S. Plan to Reduce Cancer Deaths 05/10/2023

Imagine a doctor tells you “We have found something in your body that might be cancer. But we don’t know, for sure, so we will just watch it. Come back in twelve months, and we will check if it has grown by then.” You go home that day and then worry for a year whether you have cancer. If you do, you will have lost a precious year of treatment that might have prevented metastases. Sounds crazy? Happens millions of times a year. We don’t just need more early detection - we need more Early Intervention to save thousands of lives every year. Today we published this opinion piece in Newsweek.

Marc Andreessen Reid Garrett Hoffman Jorge Conde Khosla Ventures Vinod Khosla

One Glaring Problem in the U.S. Plan to Reduce Cancer Deaths We need early cancer detection that leads to early intervention.

01/05/2023

How best to describe the spirit at Earli? Well, perhaps Halloween is a good example. Things can get rather interesting at Earli. :)
https://www.earli.com/post/an-earli-halloween

A Proactive Way to Detect Cancer at Its Earliest Stages 12/08/2022

As a Holiday gift, Earli's story and technology is featured in WIRED magazine. 🙂
How would a world look like where we could find AND treat cancer at the earliest stages? It may be hard to believe, but it's true: Early detection is the *single biggest* lever to increase survival rates of cancer - more than any medicine or treatment. For lung cancer, the difference between a Stage 1 detection and Stage 4 detection is a 10x (!) higher 5-year survival rate. Liver cancer - 12x. Pancreatic cancer - 14x.
Were going for a moonshot at Earli. Wish us luck. We are getting closer and closer.
https://www.wired.com/story/making-cancer-reveal-itself/
WIRED Khosla Ventures Perceptive Advisors World Economic Forum

A Proactive Way to Detect Cancer at Its Earliest Stages Medtech firm Earli is working on a way to make tumors announce themselves as they appear—and even provide directions to where they are in the body.

What if biotechnology could cure cancer? 06/29/2022

This is Earli, Inc.'s co-founder and CEO Cyriac Roeding's recent interview with the City of Sydney's entrepreneurship program and Sallyann Williams, the CEO of Cicada Innovations, a thriving Australian co-working space. The Australian entrepreneurship community is alive, and Australia is the place to go for clinical trials done faster and yet at top notch quality.

What if biotechnology could cure cancer? Forty percent of us will develop cancer in our lifetime. What if we found and treated cancer early? How many lives could it save? How much burden would it ta...

‘Turning a Spark Into a Bonfire’: An Interview with Earli CSO David Suhy 01/18/2022

Leading-edge science is at the core of Earli. Here is the interview with the person who is responsible at Earli for turning ideas into bonfires of action. Co-founder and chief scientific officer David Suhy.

‘Turning a Spark Into a Bonfire’: An Interview with Earli CSO David Suhy An interview with David Suhy, the Chief Science Officer and cofounder of Earli, on synthetic biopsy, the benefits of working on medical tech in a commercial context, and more.

07/21/2021

What the Hack Is A Lab-a-thon? Read here: https://blog.earli.com/.../2021-07-20-what-the-hack-is-a.../
We just decided to go crazy and try this. I think this might be a first in biotech.

06/07/2021

A big step for global visibility: The World Economic Forum has named Earli, Inc. a Global Innovator, which is an invitation-only group of about 100 of “the world’s most promising start-ups and scale-ups.” We will bring in our expertise in early cancer detection to support a core mission of the World Economic Forum to shape the future of health and healthcare. The Forum and Earli share the belief that good healthcare should be a fundamental human right anywhere around the world.

https://blog.earli.com/blog/2021-06-07-world-economic-forum-names-earli-a-global-innovator/

06/02/2021

Watch nine of the world’s foremost cancer scientists and medical doctors discuss the future of early cancer detection and Earli’s role in it. Promise: it’s 10 min of fascinating people.
Earli’s Advisory Board video includes Jim Allison (discovered cancer checkpoint inhibitors, Nobel Laureate), Bob Langer (MIT professor, Co-founder Moderna), Lee Hartwell (former President of the Hutch Cancer Research Center in Seattle, Nobel Laureate), Judy Garber (Director Cancer Genetics, Dana-Farber), Alan Ashworth (President UCSF Hellen Diller Cancer Center), Pam Sharma (MD Anderson), Charlie Rudin (Chief Thoracic Cancer, Memorial Sloan Kettering), Mark Jacobstein (former Chief User Engagement Officer, Guardant Health), Phil Greenberg (co-founder Juno, Head of Immunology at Hutch).

Exposing cancer, featuring Cyriac Roeding of Earli » Tough Tech Today with Meyen and Miller 03/23/2021

Just in! The Tough Tech podcast interviews Cyriac Roeding, our Earli Co-Founder and CEO.

https://toughtechtoday.com/exposing-cancer/

Exposing cancer, featuring Cyriac Roeding of Earli » Tough Tech Today with Meyen and Miller We can make cancer cells tell us exactly where they are. Consumer internet entrepreneurs lack many of the skills for the life sciences revolution – or do they? Cyriac Roeding, CEO and co-founder of Earli, shows us what his team of bioengineers are accomplishing by applying fast-learning software d...

01/13/2021
Earli Raises $40 Million Series A Funding Led by Khosla Ventures, With Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital 01/12/2021

The full story:

https://www.businesswire.com/news/home/20210112005302/en/

Earli Raises $40 Million Series A Funding Led by Khosla Ventures, With Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital Earli Raises $40 Million Series A Funding Led by Khosla Ventures, With Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital

This Company Raised $40 Million To Make Tumors Reveal Themselves 01/12/2021

And out of stealth!
The really big day of course will come when we save the first patient’s life by locating her or his cancer early and making it treatable.

https://www.forbes.com/sites/leahrosenbaum/2021/01/12/this-company-raised-40-million-to-make-tumors-reveal-themselves/?sh=15666f333401

This Company Raised $40 Million To Make Tumors Reveal Themselves Biotech company Earli plans to take liquid biopsies to the next level.

Want your business to be the top-listed Engineering Company in Redwood City?
Click here to claim your Sponsored Listing.

Videos (show all)

Some of the World's Leading Cancer Scientists and MDs on the Future of Early Detection

Category

Address


1400 Bridge Parkway
Redwood City, CA
94065

Other Biotechnology in Redwood City (show all)
QIAGEN Digital Insights QIAGEN Digital Insights
1001 Marshall Street, Suite 200
Redwood City, CA94063

We are committed to supporting improvements in life by developing software solutions for scientists

Achelois BioPharma Achelois BioPharma
3698 Haven Avenue , Ste. A
Redwood City, 94063

Achelois BioPharma develops curative, programmable Multivalent Therapeutics to treat cancer, viral i

biomea fusion biomea fusion
900 Middlefield Road, 4th Floor
Redwood City, 94063

We are creating an entirely new Generation of Precision Medicine against Genetically Defined Diseases.

FlashDx FlashDx
303 Twin Dolphin Drive, Suite 600
Redwood City, 94065

FlashDx, Near-patient molecular syndromic testing solutions.

Talis Biomedical Talis Biomedical
3400 Bridge Pkwy
Redwood City, 94065

Taking point-of-care to new heights with both Antigen and Molecular testing options to meet testing needs and keep life moving.

Seer Inc. Seer Inc.
3800 Bridge Parkway Suite 102
Redwood City, 94065

We empower the scientific community through the power of proteomics.

Aurora SFC Systems, Inc. Aurora SFC Systems, Inc.
1755 E Bayshore Road, Ste 25B
Redwood City, 94063

Synthego Synthego
3696 Haven Avenue, Suite A
Redwood City, 94063

The leading provider of synthetic RNA solutions for CRISPR Genome Engineering.

Rezolute Rezolute
275 Shoreline Drive, Ste. 500
Redwood City, 94065

Rezolute is dedicated to developing transformative therapies for patients suffering from debilitating metabolic diseases.